Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization
Sarah D. Burnett, Alexander D. Blanchette, Weihsueh A. Chiu, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 8, pp. 887-902
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care
Masaru Tanaka
Biomedicines (2025) Vol. 13, Iss. 1, pp. 167-167
Open Access | Times Cited: 1
The key characteristics of cardiotoxicity for the pervasive pollutant phenanthrene
E. M. England, J.W. Morris, Cyrill Bussy, et al.
Journal of Hazardous Materials (2024) Vol. 469, pp. 133853-133853
Open Access | Times Cited: 7
Chemical and biological assessments of environmental mixtures: A review of current trends, advances, and future perspectives
Yu‐Syuan Luo, Zunwei Chen, Nan‐Hung Hsieh, et al.
Journal of Hazardous Materials (2022) Vol. 432, pp. 128658-128658
Closed Access | Times Cited: 26
Engineering approaches for cardiac organoid formation and their characterization
Binata Joddar, Sylvia Natividad-Diaz, Andie E. Padilla, et al.
Translational research (2022) Vol. 250, pp. 46-67
Open Access | Times Cited: 24
Model systems and organisms for addressing inter- and intra-species variability in risk assessment
Ivan Rusyn, Weihsueh A. Chiu, Fred A. Wright
Regulatory Toxicology and Pharmacology (2022) Vol. 132, pp. 105197-105197
Open Access | Times Cited: 23
Derivation of cardiac reference ranges for Mus musculus using the Collaborative Cross and identification of new cardiac models
Julia Popp, Krishna Patel, Danila Cuomo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple Donors
Sarah D. Burnett, Alexander D. Blanchette, Weihsueh A. Chiu, et al.
Chemical Research in Toxicology (2021) Vol. 34, Iss. 9, pp. 2110-2124
Open Access | Times Cited: 31
Human sodium current voltage‐dependence at physiological temperature measured by coupling a patch‐clamp experiment to a mathematical model
Veronika O. Abrasheva, Kovalenko Sandaara, Mihail Slotvitsky, et al.
The Journal of Physiology (2024) Vol. 602, Iss. 4, pp. 633-661
Open Access | Times Cited: 4
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes
Han‐Hsuan D. Tsai, Lucie C. Ford, Zunwei Chen, et al.
ALTEX (2024)
Open Access | Times Cited: 4
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions
Jyotsna Joshi, C. Albers, Nathan Smole, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 4
Beyond pharmaceuticals: Fit-for-purpose new approach methodologies for environmental cardiotoxicity testing
Mark C. Daley
ALTEX (2022)
Open Access | Times Cited: 16
FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for in vitro pharmacology
Samuel Finkel, Shannon Sweet, Tyler Locke, et al.
APL Bioengineering (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 10
Characterizing PFAS hazards and risks: a human population-based in vitro cardiotoxicity assessment strategy
Lucie C. Ford, Hsing‐Chieh Lin, Yi‐Hui Zhou, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
A tiered approach to population-based in vitro testing for cardiotoxicity: Balancing estimates of potency and variability
Alexander D. Blanchette, Sarah D. Burnett, Ivan Rusyn, et al.
Journal of Pharmacological and Toxicological Methods (2022) Vol. 114, pp. 107154-107154
Open Access | Times Cited: 15
Key Characteristics of Cardiovascular Toxicants
Lars Lind, Jesús A. Araujo, Aaron Barchowsky, et al.
Environmental Health Perspectives (2021) Vol. 129, Iss. 9
Open Access | Times Cited: 19
Integrating nonlinear analysis and machine learning for human induced pluripotent stem cell‐based drug cardiotoxicity testing
Andrew Kowalczewski, Courtney Sakolish, Plansky Hoang, et al.
Journal of Tissue Engineering and Regenerative Medicine (2022) Vol. 16, Iss. 8, pp. 732-743
Open Access | Times Cited: 13
Review: Human stem cell-based 3D in vitro angiogenesis models for preclinical drug screening applications
Aibhlin Esparza, Nicole Jimenez, Edgar A. Borrego, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 2
Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departure
En‐Hsuan Lu, Lucie C. Ford, Zunwei Chen, et al.
Regulatory Toxicology and Pharmacology (2024) Vol. 148, pp. 105596-105596
Closed Access | Times Cited: 2
Potential Human Health Hazard of Post-Hurricane Harvey Sediments in Galveston Bay and Houston Ship Channel: A Case Study of Using In Vitro Bioactivity Data to Inform Risk Management Decisions
Zunwei Chen, Suji Jang, James M. Kaihatu, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 24, pp. 13378-13378
Open Access | Times Cited: 13
In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment
Mark C. Daley, Marjory Moreau, Peter Bronk, et al.
Toxicological Sciences (2024) Vol. 201, Iss. 1, pp. 145-157
Closed Access | Times Cited: 1
An in vitro-in silico workflow for predicting renal clearance of PFAS
Hsing‐Chieh Lin, Courtney Sakolish, Haley L. Moyer, et al.
Toxicology and Applied Pharmacology (2024) Vol. 489, pp. 117015-117015
Closed Access | Times Cited: 1
Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
Han‐Hsuan D. Tsai, Lucie C. Ford, Sarah D. Burnett, et al.
Chemical Research in Toxicology (2024) Vol. 37, Iss. 8, pp. 1428-1444
Closed Access | Times Cited: 1
Incorporating new approach methods (NAMs) data in dose–response assessments: The future is now!
En‐Hsuan Lu, Ivan Rusyn, Weihsueh A. Chiu
Journal of Toxicology and Environmental Health Part B (2024), pp. 1-35
Open Access | Times Cited: 1
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products
Liam Simms, Fan Yu, Jessica Palmer, et al.
Frontiers in Toxicology (2022) Vol. 4
Open Access | Times Cited: 7
Cumulative Risk Meets Inter-Individual Variability: Probabilistic Concentration Addition of Complex Mixture Exposures in a Population-Based Human In Vitro Model
Suji Jang, Lucie C. Ford, Ivan Rusyn, et al.
Toxics (2022) Vol. 10, Iss. 10, pp. 549-549
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top